Shares of Mindray Medical International (NYSE:MR) traded at a new 52-week high today of $38.97. So far today approximately 307,000 shares have been exchanged, as compared to an average 30-day volume of 743,000 shares.
Mindray Medical International Limited develops, manufactures, and markets medical devices. The Company offers patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems.
In the past 52 weeks, Mindray Medical International share prices have been bracketed by a low of $26.17 and a high of $38.97 and are now at $38.91, 49% above that low price. The 200-day and 50-day moving averages have moved 0.36% higher and 1.02% higher over the past week, respectively.
Mindray Medical International (NYSE:MR) has potential upside of 0.7% based on a current price of $38.91 and analysts' consensus price target of $39.17. The stock should discover initial support at its 50-day moving average (MA) of $36.95 and subsequent support at its 200-day MA of $33.87.